 | • レポートコード：MRCLP3DB6542 • 出版社/出版日：LP Information / 2023年12月 • レポート形態：英文、PDF、112ページ • 納品方法：Eメール（納期：2-3営業日） • 産業分類：医薬品＆医療 |
| Single User | ￥549,000 (USD3,660) | ▷ お問い合わせ |
| Corporate User | ￥1,098,000 (USD7,320) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| LPインフォメーション社の最新調査レポート「抗炎症のどスプレーの世界市場」は、過去の販売実績から2022年の世界の抗炎症のどスプレーの総販売量を検討し、2023年から2029年の予測される抗炎症のどスプレーの販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の抗炎症のどスプレーの市場規模を掲載し、XXX百万米ドル規模の世界の抗炎症のどスプレー市場の詳細な分析を提供します。本インサイトレポートは、世界の抗炎症のどスプレー業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。 また、本資料では、加速する世界の抗炎症のどスプレー市場における各社の独自のポジションをより深く理解するために、抗炎症のどスプレー製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。 世界の抗炎症のどスプレー市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。抗炎症のどスプレーの米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。抗炎症のどスプレーの中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。抗炎症のどスプレーの欧州市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。 抗炎症のどスプレーの世界主要メーカーとしては、Prestige Consumer Healthcare Inc.、 Reckitt Benckiser Group PLC.、 Purdue Pharma、 Procter & Gamble、 Cipla Limited、 iNova Pharmaceuticals (Difflam)、 Marinomed Biotech AG、 Biocidin Botanicals、 URSATEC GmbH、 Martin & Pleasance、 Mega We Care、 PFL Healthcare (Snoreeze)、 Zenta Healthcare Private Limited、 Puressentiel Laboratory、 Melcare Biomedicalなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。 本調査資料では、製品タイプ、用途、主要メーカー、主要地域、国別の抗炎症のどスプレー市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。 【市場細分化】 本調査では抗炎症のどスプレー市場をセグメンテーションし、種類別 (急性喉スプレー、慢性喉スプレー)、用途別 (病院、診療所、薬局、その他)、および地域別 (アジア太平洋、南北アメリカ、欧州、および中東・アフリカ) の市場規模を予測しています。 ・種類別区分：急性喉スプレー、慢性喉スプレー ・用途別区分：病院、診療所、薬局、その他 ・地域別区分 南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル） アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア） 欧州（ドイツ、フランス、イギリス、イタリア、ロシア） 中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国） 【本レポートで扱う主な質問】 ・世界の抗炎症のどスプレー市場の10年間の市場状況・展望は？ ・世界および地域別に見た抗炎症のどスプレー市場成長の要因は何か？ ・抗炎症のどスプレーの市場機会はエンドマーケットの規模によってどのように変化するのか？ ・抗炎症のどスプレーのタイプ別、用途別の内訳は？ ・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？ ********* 目次 ********* レポートの範囲 ・市場の紹介 ・分析対象期間 ・調査の目的 ・調査手法 ・調査プロセスおよびデータソース ・経済指標 ・通貨 エグゼクティブサマリー ・世界市場の概要：抗炎症のどスプレーの年間販売量2018-2029、地域別現状・将来分析 ・抗炎症のどスプレーの種類別セグメント：急性喉スプレー、慢性喉スプレー ・抗炎症のどスプレーの種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格 ・抗炎症のどスプレーの用途別セグメント：病院、診療所、薬局、その他 ・抗炎症のどスプレーの用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格 企業別世界の抗炎症のどスプレー市場 ・企業別のグローバル抗炎症のどスプレー市場データ：2018-2023年の年間販売量、市場シェア ・企業別の抗炎症のどスプレーの年間売上：2018-2023年の売上、市場シェア ・企業別の抗炎症のどスプレー販売価格 ・主要企業の抗炎症のどスプレー生産地域、販売地域、製品タイプ ・市場集中度分析 ・新製品および潜在的な参加者 ・合併と買収、拡大 抗炎症のどスプレーの地域別レビュー ・地域別の抗炎症のどスプレー市場規模2018-2023：年間販売量、売上 ・主要国別の抗炎症のどスプレー市場規模2018-2023：年間販売量、売上 ・南北アメリカの抗炎症のどスプレー販売の成長 ・アジア太平洋の抗炎症のどスプレー販売の成長 ・欧州の抗炎症のどスプレー販売の成長 ・中東・アフリカの抗炎症のどスプレー販売の成長 南北アメリカ市場 ・南北アメリカの国別の抗炎症のどスプレー販売量、売上（2018-2023） ・南北アメリカの抗炎症のどスプレーの種類別販売量 ・南北アメリカの抗炎症のどスプレーの用途別販売量 ・アメリカ市場 ・カナダ市場 ・メキシコ市場 ・ブラジル市場 アジア太平洋市場 ・アジア太平洋の国別の抗炎症のどスプレー販売量、売上（2018-2023） ・アジア太平洋の抗炎症のどスプレーの種類別販売量 ・アジア太平洋の抗炎症のどスプレーの用途別販売量 ・中国市場 ・日本市場 ・韓国市場 ・東南アジア市場 ・インド市場 ・オーストラリア市場 ・台湾市場 欧州市場 ・欧州の国別の抗炎症のどスプレー販売量、売上（2018-2023） ・欧州の抗炎症のどスプレーの種類別販売量 ・欧州の抗炎症のどスプレーの用途別販売量 ・ドイツ市場 ・フランス市場 ・イギリス市場 ・イタリア市場 ・ロシア市場 中東・アフリカ市場 ・中東・アフリカの国別の抗炎症のどスプレー販売量、売上（2018-2023） ・中東・アフリカの抗炎症のどスプレーの種類別販売量 ・中東・アフリカの抗炎症のどスプレーの用途別販売量 ・エジプト市場 ・南アフリカ市場 ・イスラエル市場 ・トルコ市場 ・GCC諸国市場 市場の成長要因、課題、動向 ・市場の成長要因および成長機会分析 ・市場の課題およびリスク ・市場動向 製造コスト構造分析 ・原材料とサプライヤー ・抗炎症のどスプレーの製造コスト構造分析 ・抗炎症のどスプレーの製造プロセス分析 ・抗炎症のどスプレーの産業チェーン構造 マーケティング、販売業者および顧客 ・販売チャンネル：直接販売チャンネル、間接販売チャンネル ・抗炎症のどスプレーの主要なグローバル販売業者 ・抗炎症のどスプレーの主要なグローバル顧客 地域別の抗炎症のどスプレー市場予測レビュー ・地域別の抗炎症のどスプレー市場規模予測（2024-2029） ・南北アメリカの国別予測 ・アジア太平洋の国別予測 ・欧州の国別予測 ・抗炎症のどスプレーの種類別市場規模予測 ・抗炎症のどスプレーの用途別市場規模予測 主要企業分析 Prestige Consumer Healthcare Inc.、 Reckitt Benckiser Group PLC.、 Purdue Pharma、 Procter & Gamble、 Cipla Limited、 iNova Pharmaceuticals (Difflam)、 Marinomed Biotech AG、 Biocidin Botanicals、 URSATEC GmbH、 Martin & Pleasance、 Mega We Care、 PFL Healthcare (Snoreeze)、 Zenta Healthcare Private Limited、 Puressentiel Laboratory、 Melcare Biomedical ・企業情報 ・抗炎症のどスプレー製品 ・抗炎症のどスプレー販売量、売上、価格、粗利益（2018-2023） ・主要ビジネス概要 ・最新動向 調査結果および結論 |
The global Anti-inflammatory Throat Spray market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Anti-inflammatory Throat Spray is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Anti-inflammatory Throat Spray is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Anti-inflammatory Throat Spray is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Anti-inflammatory Throat Spray players cover Prestige Consumer Healthcare Inc., Reckitt Benckiser Group PLC., Purdue Pharma, Procter & Gamble, Cipla Limited, iNova Pharmaceuticals (Difflam), Marinomed Biotech AG, Biocidin Botanicals and URSATEC GmbH, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)’ newest research report, the “Anti-inflammatory Throat Spray Industry Forecast” looks at past sales and reviews total world Anti-inflammatory Throat Spray sales in 2022, providing a comprehensive analysis by region and market sector of projected Anti-inflammatory Throat Spray sales for 2023 through 2029. With Anti-inflammatory Throat Spray sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Anti-inflammatory Throat Spray industry.
This Insight Report provides a comprehensive analysis of the global Anti-inflammatory Throat Spray landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Anti-inflammatory Throat Spray portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Anti-inflammatory Throat Spray market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Anti-inflammatory Throat Spray and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Anti-inflammatory Throat Spray.
This report presents a comprehensive overview, market shares, and growth opportunities of Anti-inflammatory Throat Spray market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Acute Throat Spray
Chronic Throat Spray
Segmentation by application
Hospital
Clinic
Drugstore
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Prestige Consumer Healthcare Inc.
Reckitt Benckiser Group PLC.
Purdue Pharma
Procter & Gamble
Cipla Limited
iNova Pharmaceuticals (Difflam)
Marinomed Biotech AG
Biocidin Botanicals
URSATEC GmbH
Martin & Pleasance
Mega We Care
PFL Healthcare (Snoreeze)
Zenta Healthcare Private Limited
Puressentiel Laboratory
Melcare Biomedical
Key Questions Addressed in this Report
What is the 10-year outlook for the global Anti-inflammatory Throat Spray market?
What factors are driving Anti-inflammatory Throat Spray market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Anti-inflammatory Throat Spray market opportunities vary by end market size?
How does Anti-inflammatory Throat Spray break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Anti-inflammatory Throat Spray Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Anti-inflammatory Throat Spray by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Anti-inflammatory Throat Spray by Country/Region, 2018, 2022 & 2029
2.2 Anti-inflammatory Throat Spray Segment by Type
2.2.1 Acute Throat Spray
2.2.2 Chronic Throat Spray
2.3 Anti-inflammatory Throat Spray Sales by Type
2.3.1 Global Anti-inflammatory Throat Spray Sales Market Share by Type (2018-2023)
2.3.2 Global Anti-inflammatory Throat Spray Revenue and Market Share by Type (2018-2023)
2.3.3 Global Anti-inflammatory Throat Spray Sale Price by Type (2018-2023)
2.4 Anti-inflammatory Throat Spray Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Drugstore
2.4.4 Other
2.5 Anti-inflammatory Throat Spray Sales by Application
2.5.1 Global Anti-inflammatory Throat Spray Sale Market Share by Application (2018-2023)
2.5.2 Global Anti-inflammatory Throat Spray Revenue and Market Share by Application (2018-2023)
2.5.3 Global Anti-inflammatory Throat Spray Sale Price by Application (2018-2023)
3 Global Anti-inflammatory Throat Spray by Company
3.1 Global Anti-inflammatory Throat Spray Breakdown Data by Company
3.1.1 Global Anti-inflammatory Throat Spray Annual Sales by Company (2018-2023)
3.1.2 Global Anti-inflammatory Throat Spray Sales Market Share by Company (2018-2023)
3.2 Global Anti-inflammatory Throat Spray Annual Revenue by Company (2018-2023)
3.2.1 Global Anti-inflammatory Throat Spray Revenue by Company (2018-2023)
3.2.2 Global Anti-inflammatory Throat Spray Revenue Market Share by Company (2018-2023)
3.3 Global Anti-inflammatory Throat Spray Sale Price by Company
3.4 Key Manufacturers Anti-inflammatory Throat Spray Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Anti-inflammatory Throat Spray Product Location Distribution
3.4.2 Players Anti-inflammatory Throat Spray Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Anti-inflammatory Throat Spray by Geographic Region
4.1 World Historic Anti-inflammatory Throat Spray Market Size by Geographic Region (2018-2023)
4.1.1 Global Anti-inflammatory Throat Spray Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Anti-inflammatory Throat Spray Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Anti-inflammatory Throat Spray Market Size by Country/Region (2018-2023)
4.2.1 Global Anti-inflammatory Throat Spray Annual Sales by Country/Region (2018-2023)
4.2.2 Global Anti-inflammatory Throat Spray Annual Revenue by Country/Region (2018-2023)
4.3 Americas Anti-inflammatory Throat Spray Sales Growth
4.4 APAC Anti-inflammatory Throat Spray Sales Growth
4.5 Europe Anti-inflammatory Throat Spray Sales Growth
4.6 Middle East & Africa Anti-inflammatory Throat Spray Sales Growth
5 Americas
5.1 Americas Anti-inflammatory Throat Spray Sales by Country
5.1.1 Americas Anti-inflammatory Throat Spray Sales by Country (2018-2023)
5.1.2 Americas Anti-inflammatory Throat Spray Revenue by Country (2018-2023)
5.2 Americas Anti-inflammatory Throat Spray Sales by Type
5.3 Americas Anti-inflammatory Throat Spray Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Anti-inflammatory Throat Spray Sales by Region
6.1.1 APAC Anti-inflammatory Throat Spray Sales by Region (2018-2023)
6.1.2 APAC Anti-inflammatory Throat Spray Revenue by Region (2018-2023)
6.2 APAC Anti-inflammatory Throat Spray Sales by Type
6.3 APAC Anti-inflammatory Throat Spray Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Anti-inflammatory Throat Spray by Country
7.1.1 Europe Anti-inflammatory Throat Spray Sales by Country (2018-2023)
7.1.2 Europe Anti-inflammatory Throat Spray Revenue by Country (2018-2023)
7.2 Europe Anti-inflammatory Throat Spray Sales by Type
7.3 Europe Anti-inflammatory Throat Spray Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Anti-inflammatory Throat Spray by Country
8.1.1 Middle East & Africa Anti-inflammatory Throat Spray Sales by Country (2018-2023)
8.1.2 Middle East & Africa Anti-inflammatory Throat Spray Revenue by Country (2018-2023)
8.2 Middle East & Africa Anti-inflammatory Throat Spray Sales by Type
8.3 Middle East & Africa Anti-inflammatory Throat Spray Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Anti-inflammatory Throat Spray
10.3 Manufacturing Process Analysis of Anti-inflammatory Throat Spray
10.4 Industry Chain Structure of Anti-inflammatory Throat Spray
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Anti-inflammatory Throat Spray Distributors
11.3 Anti-inflammatory Throat Spray Customer
12 World Forecast Review for Anti-inflammatory Throat Spray by Geographic Region
12.1 Global Anti-inflammatory Throat Spray Market Size Forecast by Region
12.1.1 Global Anti-inflammatory Throat Spray Forecast by Region (2024-2029)
12.1.2 Global Anti-inflammatory Throat Spray Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Anti-inflammatory Throat Spray Forecast by Type
12.7 Global Anti-inflammatory Throat Spray Forecast by Application
13 Key Players Analysis
13.1 Prestige Consumer Healthcare Inc.
13.1.1 Prestige Consumer Healthcare Inc. Company Information
13.1.2 Prestige Consumer Healthcare Inc. Anti-inflammatory Throat Spray Product Portfolios and Specifications
13.1.3 Prestige Consumer Healthcare Inc. Anti-inflammatory Throat Spray Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Prestige Consumer Healthcare Inc. Main Business Overview
13.1.5 Prestige Consumer Healthcare Inc. Latest Developments
13.2 Reckitt Benckiser Group PLC.
13.2.1 Reckitt Benckiser Group PLC. Company Information
13.2.2 Reckitt Benckiser Group PLC. Anti-inflammatory Throat Spray Product Portfolios and Specifications
13.2.3 Reckitt Benckiser Group PLC. Anti-inflammatory Throat Spray Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Reckitt Benckiser Group PLC. Main Business Overview
13.2.5 Reckitt Benckiser Group PLC. Latest Developments
13.3 Purdue Pharma
13.3.1 Purdue Pharma Company Information
13.3.2 Purdue Pharma Anti-inflammatory Throat Spray Product Portfolios and Specifications
13.3.3 Purdue Pharma Anti-inflammatory Throat Spray Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Purdue Pharma Main Business Overview
13.3.5 Purdue Pharma Latest Developments
13.4 Procter & Gamble
13.4.1 Procter & Gamble Company Information
13.4.2 Procter & Gamble Anti-inflammatory Throat Spray Product Portfolios and Specifications
13.4.3 Procter & Gamble Anti-inflammatory Throat Spray Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Procter & Gamble Main Business Overview
13.4.5 Procter & Gamble Latest Developments
13.5 Cipla Limited
13.5.1 Cipla Limited Company Information
13.5.2 Cipla Limited Anti-inflammatory Throat Spray Product Portfolios and Specifications
13.5.3 Cipla Limited Anti-inflammatory Throat Spray Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Cipla Limited Main Business Overview
13.5.5 Cipla Limited Latest Developments
13.6 iNova Pharmaceuticals (Difflam)
13.6.1 iNova Pharmaceuticals (Difflam) Company Information
13.6.2 iNova Pharmaceuticals (Difflam) Anti-inflammatory Throat Spray Product Portfolios and Specifications
13.6.3 iNova Pharmaceuticals (Difflam) Anti-inflammatory Throat Spray Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 iNova Pharmaceuticals (Difflam) Main Business Overview
13.6.5 iNova Pharmaceuticals (Difflam) Latest Developments
13.7 Marinomed Biotech AG
13.7.1 Marinomed Biotech AG Company Information
13.7.2 Marinomed Biotech AG Anti-inflammatory Throat Spray Product Portfolios and Specifications
13.7.3 Marinomed Biotech AG Anti-inflammatory Throat Spray Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Marinomed Biotech AG Main Business Overview
13.7.5 Marinomed Biotech AG Latest Developments
13.8 Biocidin Botanicals
13.8.1 Biocidin Botanicals Company Information
13.8.2 Biocidin Botanicals Anti-inflammatory Throat Spray Product Portfolios and Specifications
13.8.3 Biocidin Botanicals Anti-inflammatory Throat Spray Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Biocidin Botanicals Main Business Overview
13.8.5 Biocidin Botanicals Latest Developments
13.9 URSATEC GmbH
13.9.1 URSATEC GmbH Company Information
13.9.2 URSATEC GmbH Anti-inflammatory Throat Spray Product Portfolios and Specifications
13.9.3 URSATEC GmbH Anti-inflammatory Throat Spray Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 URSATEC GmbH Main Business Overview
13.9.5 URSATEC GmbH Latest Developments
13.10 Martin & Pleasance
13.10.1 Martin & Pleasance Company Information
13.10.2 Martin & Pleasance Anti-inflammatory Throat Spray Product Portfolios and Specifications
13.10.3 Martin & Pleasance Anti-inflammatory Throat Spray Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Martin & Pleasance Main Business Overview
13.10.5 Martin & Pleasance Latest Developments
13.11 Mega We Care
13.11.1 Mega We Care Company Information
13.11.2 Mega We Care Anti-inflammatory Throat Spray Product Portfolios and Specifications
13.11.3 Mega We Care Anti-inflammatory Throat Spray Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Mega We Care Main Business Overview
13.11.5 Mega We Care Latest Developments
13.12 PFL Healthcare (Snoreeze)
13.12.1 PFL Healthcare (Snoreeze) Company Information
13.12.2 PFL Healthcare (Snoreeze) Anti-inflammatory Throat Spray Product Portfolios and Specifications
13.12.3 PFL Healthcare (Snoreeze) Anti-inflammatory Throat Spray Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 PFL Healthcare (Snoreeze) Main Business Overview
13.12.5 PFL Healthcare (Snoreeze) Latest Developments
13.13 Zenta Healthcare Private Limited
13.13.1 Zenta Healthcare Private Limited Company Information
13.13.2 Zenta Healthcare Private Limited Anti-inflammatory Throat Spray Product Portfolios and Specifications
13.13.3 Zenta Healthcare Private Limited Anti-inflammatory Throat Spray Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Zenta Healthcare Private Limited Main Business Overview
13.13.5 Zenta Healthcare Private Limited Latest Developments
13.14 Puressentiel Laboratory
13.14.1 Puressentiel Laboratory Company Information
13.14.2 Puressentiel Laboratory Anti-inflammatory Throat Spray Product Portfolios and Specifications
13.14.3 Puressentiel Laboratory Anti-inflammatory Throat Spray Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Puressentiel Laboratory Main Business Overview
13.14.5 Puressentiel Laboratory Latest Developments
13.15 Melcare Biomedical
13.15.1 Melcare Biomedical Company Information
13.15.2 Melcare Biomedical Anti-inflammatory Throat Spray Product Portfolios and Specifications
13.15.3 Melcare Biomedical Anti-inflammatory Throat Spray Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Melcare Biomedical Main Business Overview
13.15.5 Melcare Biomedical Latest Developments
14 Research Findings and Conclusion